4//SEC Filing
Lion Biotechnologies, Inc. 4
Accession 0001250853-17-000050
$IOVACIK 0001425205operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:31 PM ET
Size
5.6 KB
Accession
0001250853-17-000050
Insider Transaction Report
Form 4
Hillsberg Sanford
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-01+35,000→ 35,000 totalExercise: $5.45Exp: 2027-05-31→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated.
Documents
Issuer
Lion Biotechnologies, Inc.
CIK 0001425205
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001425205
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:31 PM ET
- Size
- 5.6 KB